Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

ClinicalTrials.gov ID: NCT06164704

Public ClinicalTrials.gov record NCT06164704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)

Study identification

NCT ID
NCT06164704
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Upstream Bio Inc.
Industry
Enrollment
81 participants

Conditions and interventions

Interventions

  • Verekitug (UPB-101) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2023
Primary completion
Jul 6, 2025
Completion
Jul 21, 2025
Last update posted
Aug 14, 2025

2023 – 2025

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Sensa Health LA (Sensa Health Clinical Research) Los Angeles California 90006
NewportNativeMD, Inc. Newport Beach California 92782
DaVinci, Research LLC Roseville California 95661
Senta Clinic San Diego California 92108
University of Missouri Columbus Colorado 65212
Western States Clinical Research, Inc. Wheat Ridge Colorado 80033
Alfa Medical Research Hollywood Florida 33024
Novaceut Clinical Research Miami Florida 33013
Well Pharma Medical Research Corp. Miami Florida 33173
IMIC Inc. Miami Florida 33176
University of South Florida Tampa Florida 33613-3923
Treasure Valley Medical Research Boise Idaho 83706
The University of Chicago Chicago Illinois 60637
Advanced ENT and Allergy Louisville Kentucky 40220
Chesapeake Clinical Research, Inc. White Marsh Maryland 21162
Brigham and Women's Hospital Boston Massachusetts 02115
Northwell Health/Division of Allergy and Immunology Great Neck New York 11021
University of Cincinnati Medical Center Cincinnati Ohio 45106
Allergy, Asthma & Clinical Research Center Oklahoma City Oklahoma 73120-9389
Spartanburg /Greer ENT & Allergy Spartanburg South Carolina 29303
Orion Clinical Research Austin Texas 78759
Alina Clinical Trials, LLC. Dallas Texas 75209
Ears Nose and Throat Associates of Texas McKinney Texas 75070
Alamo Ent Associates San Antonio Texas 78258
Eastern Virginia Medical School Norfolk Virginia 23507-1904
Bellingham Asthma, Allergy & Immunology Clinic Bellingham Washington 98225
Allergy, Asthma and Sinus Center, S.C. Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06164704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06164704 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →